| 7001 | Thyroiditis, unspecified | FING00001359 | 0.01 |
| 7002 | GRAP2/SRC ratio | GCST90314989 | 0.01 |
| 7003 | Glucose levels (UKB data field 23470) | GCST90269567 | 0.01 |
| 7004 | Blood urea nitrogen levels | GCST90018728 | 0.01 |
| 7005 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 118) | GCST90320937 | 0.01 |
| 7006 | Early lumbar disc prolapse, operated | FING00000484 | 0.01 |
| 7007 | Placental weight (maternal genotype, adjusted for sex) | GCST90275198 | 0.01 |
| 7008 | MME/NT5E ratio | GCST90315460 | 0.01 |
| 7009 | Estimated glomerular filtration rate based on creatinine and cystatin C in bottom 99% of individuals by creatinine levels | GCST90566737 | 0.01 |
| 7010 | ANG/RARRES2 ratio | GCST90313271 | 0.01 |
| 7011 | EHD3 levels | GCST90469089 | 0.01 |
| 7012 | Vitamin D | Blood biochemistry | UKBB00000902 | 0.01 |
| 7013 | NUBP1 levels | GCST90470100 | 0.01 |
| 7014 | Volume of left anterior amygdaloid area | GCST90474937 | 0.01 |
| 7015 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T251 | ECGA000251 | 0.01 |
| 7016 | RAB31 levels | GCST90087552 | 0.01 |
| 7017 | Mean sphered cell volume (UKB data field 30270) | GCST90468089 | 0.01 |
| 7018 | Familial combined hyperlipidemia defined by Brunzell criteria | GCST90104003 | 0.01 |
| 7019 | Triglyceride levels in very small VLDL | GCST90093038 | 0.01 |
| 7020 | T1 FreeSurfer a2009s rh S calcarine area | GCST90384933 | 0.01 |
| 7021 | Tibia length to body height ratio | GCST90270258 | 0.01 |
| 7022 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T164 | ECGA000164 | 0.01 |
| 7023 | ECE1 levels | GCST90469061 | 0.01 |
| 7024 | Total concentration of lipoprotein particles (UKB data field 23427) | GCST90269524 | 0.01 |
| 7025 | AKT1S1/FHIT ratio | GCST90313228 | 0.01 |
| 7026 | ANP32B levels | GCST90240176 | 0.01 |
| 7027 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T151 | ECGA000151 | 0.01 |
| 7028 | Prostate cancer | GCST90274714 | 0.01 |
| 7029 | T1 FreeSurfer aseg Right-Pallidum | GCST90384164 | 0.01 |
| 7030 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T250 | ECGA000250 | 0.01 |
| 7031 | Coronary artery bypass grafting | FING00000358 | 0.01 |
| 7032 | IDP dMRI TBSS OD Superior corona radiata L | GCST90004427 | 0.01 |
| 7033 | SAP18 levels | GCST90241432 | 0.01 |
| 7034 | NOS1 levels | GCST90470062 | 0.01 |
| 7035 | COMP/THBS4 ratio | GCST90314193 | 0.01 |
| 7036 | Triglycerides in VLDL (UKB data field 23408) | GCST90269505 | 0.01 |
| 7037 | T1 FreeSurfer a2009s lh S temporal sup area | GCST90384740 | 0.01 |
| 7038 | Non-cancer illness code, self-reported - eczema/dermatitis | Medical conditions | UKBB00000509 | 0.01 |
| 7039 | Linoleic acid levels | GCST90498309 | 0.01 |
| 7040 | Testosterone levels | GCST90483486 | 0.01 |
| 7041 | ENO2/ITGB1BP2 ratio | GCST90314661 | 0.01 |
| 7042 | DSG4 levels | GCST90469044 | 0.01 |
| 7043 | T1 FreeSurfer DKT rh lingual area | GCST90384297 | 0.01 |
| 7044 | CD84/TREML2 ratio | GCST90313919 | 0.01 |
| 7045 | aparc-a2009s rh volume S-front-inf | GCST90003050 | 0.01 |
| 7046 | HippSubfield lh volume CA3-body | GCST90002680 | 0.01 |
| 7047 | AGRP/NPY ratio | GCST90313203 | 0.01 |
| 7048 | LAT/VASH1 ratio | GCST90315289 | 0.01 |
| 7049 | Right-hemisphere visual network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302775 | 0.01 |
| 7050 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T174 | ECGA000174 | 0.01 |
| 7051 | wg rh intensity-contrast parsorbitalis | GCST90003845 | 0.01 |
| 7052 | Unstable angina pectoris | GCST90018712 | 0.01 |
| 7053 | CCN2/DKK1 ratio | GCST90313710 | 0.01 |
| 7054 | UFC1 levels | GCST90243245 | 0.01 |
| 7055 | Ventricular arrhythmia | GCST90018720 | 0.01 |
| 7056 | LCN2/RETN ratio | GCST90315308 | 0.01 |
| 7057 | LYPD8 levels | GCST90469829 | 0.01 |
| 7058 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T130 | ECGA000130 | 0.01 |
| 7059 | Intra-ocular pressure, Goldmann-correlated (left) | Intraocular pressure | UKBB00000376 | 0.01 |
| 7060 | Total lipids in small HDL | GCST90499456 | 0.01 |
| 7061 | HippSubfield rh volume hippocampal-fissure | GCST90002694 | 0.01 |
| 7062 | BCAM/NOTCH1 ratio | GCST90313474 | 0.01 |
| 7063 | Sphingomyelin_41:0_[M+H]1+ levels | GCST90060386 | 0.01 |
| 7064 | Other non-epithelial cancer of skin (PheCode 172.2) | GCST90475580 | 0.01 |
| 7065 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T157 | ECGU000157 | 0.01 |
| 7066 | Intra-ocular pressure, corneal-compensated (left) | Intraocular pressure | UKBB00000374 | 0.01 |
| 7067 | SPRY2/YTHDF3 ratio | GCST90315881 | 0.01 |
| 7068 | FTCD levels | GCST90469274 | 0.01 |
| 7069 | Diastolic blood pressure (MTAG) | GCST90449057 | 0.01 |
| 7070 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T423 | ECGU000423 | 0.01 |
| 7071 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90499287 | 0.01 |
| 7072 | Non-cancer illness code, self-reported - heart attack/myocardial infarction | Medical conditions | UKBB00000514 | 0.01 |
| 7073 | FAM171B levels | GCST90090339 | 0.01 |
| 7074 | SPINK5/SPINT1 ratio | GCST90315877 | 0.01 |
| 7075 | Kidney transplant status | FING00000710 | 0.01 |
| 7076 | Hair/balding pattern: Pattern 4 (UKB data field 2395_4) | GCST90043619 | 0.01 |
| 7077 | Phenylalanine levels | GCST90499228 | 0.01 |
| 7078 | Stenosis and insufficiency of lacrimal passages | FING00001334 | 0.01 |
| 7079 | NCS1 levels | GCST90470011 | 0.01 |
| 7080 | DTI TBSS L2 Anterior corona radiata L | GCST90384499 | 0.01 |
| 7081 | Vitamin B12 deficiency anaemia | FING00001441 | 0.01 |
| 7082 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T273 | ECGA000273 | 0.01 |
| 7083 | TAX1BP1 levels | GCST90470808 | 0.01 |
| 7084 | DCTN1/SCAMP3 ratio | GCST90314433 | 0.01 |
| 7085 | Urinary tryptophan to urinary creatinine ratio | GCST90451748 | 0.01 |
| 7086 | HCLS1/TMSB10 ratio | GCST90315043 | 0.01 |
| 7087 | Cholesterol esters in very small VLDL | GCST90500740 | 0.01 |
| 7088 | Free cholesterol in IDL | GCST90497561 | 0.01 |
| 7089 | BLMH levels | GCST90468447 | 0.01 |
| 7090 | Hernia | FING00000616 | 0.01 |
| 7091 | CLC levels | GCST90468762 | 0.01 |
| 7092 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T156 | ECGU000156 | 0.01 |
| 7093 | DEFB4A or DEFB4B levels | GCST90468984 | 0.01 |
| 7094 | Other disorders of glucose regulation and pancreatic internal secretion | FING00001028 | 0.01 |
| 7095 | IDP dMRI TBSS L2 Cerebral peduncle R | GCST90004137 | 0.01 |
| 7096 | Coeliac disease | GCST90468120 | 0.01 |
| 7097 | DTI TBSS L2 Medial lemniscus L | GCST90384485 | 0.01 |
| 7098 | Left ventricle sphericity index | GCST90268402 | 0.01 |
| 7099 | NAGK levels | GCST90469995 | 0.01 |
| 7100 | AHCY levels | GCST90468259 | 0.01 |
| 7101 | wg lh intensity-contrast lingual | GCST90003804 | 0.01 |
| 7102 | IGF1 levels | GCST90468078 | 0.01 |
| 7103 | CDH1/CDH17 ratio | GCST90313945 | 0.01 |
| 7104 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T179 | ECGA000179 | 0.01 |
| 7105 | Chronic hepatitis B infection | GCST90018584 | 0.01 |
| 7106 | CD209/GP2 ratio | GCST90313751 | 0.01 |
| 7107 | IDP dMRI TBSS FA Tapetum L | GCST90003924 | 0.01 |
| 7108 | PIK3AP1/PSMG3 ratio | GCST90315651 | 0.01 |
| 7109 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T473 | ECGU000473 | 0.01 |
| 7110 | Phosphatidylcholines levels (UKB data field 23437) | GCST90269534 | 0.01 |
| 7111 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T475 | ECGU000475 | 0.01 |
| 7112 | CX3CL1 levels | GCST90012074 | 0.01 |
| 7113 | HSPB1 levels | GCST90469489 | 0.01 |
| 7114 | ENG/TNFSF10 ratio | GCST90314651 | 0.01 |
| 7115 | height (mean, inv-normal transformed) | GCST90475362 | 0.01 |
| 7116 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86) | GCST90320905 | 0.01 |
| 7117 | IDP dMRI TBSS FA Retrolenticular part of internal capsule R | GCST90003897 | 0.01 |
| 7118 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T31 | ECGA000031 | 1.00e-02 |
| 7119 | high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed) | GCST90475354 | 1.00e-02 |
| 7120 | FADD/LACTB2 ratio | GCST90314767 | 9.99e-03 |
| 7121 | Degeneration of macula and posterior pole of retina (PheCode 362.2) | GCST90475849 | 9.96e-03 |
| 7122 | Pilonidal cyst | FING00001167 | 9.95e-03 |
| 7123 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T141 | ECGU000141 | 9.95e-03 |
| 7124 | aparc-DKTatlas lh volume precentral | GCST90002884 | 9.94e-03 |
| 7125 | Phospholipids to total lipids ratio in large LDL | GCST90092865 | 9.94e-03 |
| 7126 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T476 | ECGU000476 | 9.93e-03 |
| 7127 | Diabetes | GCST90468124 | 9.92e-03 |
| 7128 | Endometriosis ASRM stages 3,4 | FING00000498 | 9.91e-03 |
| 7129 | NFE2 levels | GCST90470035 | 9.90e-03 |
| 7130 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T8 | ECGA000008 | 9.89e-03 |
| 7131 | NXF1 levels | GCST90242149 | 9.88e-03 |
| 7132 | GNE levels | GCST90469370 | 9.88e-03 |
| 7133 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T276 | ECGA000276 | 9.88e-03 |
| 7134 | Triglycerides in large LDL (UKB data field 23536) | GCST90269633 | 9.87e-03 |
| 7135 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T274 | ECGU000274 | 9.87e-03 |
| 7136 | IDP dMRI ProbtrackX L3 cst r | GCST90004309 | 9.85e-03 |
| 7137 | COL6A3/NBL1 ratio | GCST90314176 | 9.85e-03 |
| 7138 | Valvular heart disease excluding rheumatic fever | FING00001414 | 9.84e-03 |
| 7139 | Glycosyl ceramide (d18:1/20:0, d16:1/22:0) levels | GCST90200145 | 9.84e-03 |
| 7140 | Saturated fatty acids levels (UKB data field 23448) | GCST90269545 | 9.83e-03 |
| 7141 | FABP1/FABP2 ratio | GCST90314750 | 9.83e-03 |
| 7142 | RNF149 levels | GCST90470482 | 9.82e-03 |
| 7143 | Angina pectoris | GCST90018573 | 9.82e-03 |
| 7144 | PLIN1 levels | GCST90470258 | 9.81e-03 |
| 7145 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T169 | ECGA000169 | 9.81e-03 |
| 7146 | Facial pigmentation measurement (polar light) | GCST90002284 | 9.79e-03 |
| 7147 | Spermatocele | FING00001319 | 9.79e-03 |
| 7148 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T183 | ECGU000183 | 9.79e-03 |
| 7149 | TALDO1 levels | GCST90470802 | 9.78e-03 |
| 7150 | Lumbar disc prolapse | FING00000735 | 9.76e-03 |
| 7151 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T493 | ECGA000493 | 9.75e-03 |
| 7152 | Multi-trait sex score | GCST90270118 | 9.74e-03 |
| 7153 | Plasma succinylcarnitine (C4-DC) levels in chronic kidney disease | GCST90265998 | 9.74e-03 |
| 7154 | PGR levels | GCST90470223 | 9.74e-03 |
| 7155 | CD40LG/TRAF2 ratio | GCST90313828 | 9.72e-03 |
| 7156 | Fractured bone site(s) - Wrist | Medical conditions | UKBB00000257 | 9.70e-03 |
| 7157 | mean corpuscular volume (MCV, minimum, inv-norm transformed) | GCST90475474 | 9.69e-03 |
| 7158 | Colon cancer/rectal cancer | GCST90475170 | 9.68e-03 |
| 7159 | IDP dMRI ProbtrackX FA ar r | GCST90003926 | 9.67e-03 |
| 7160 | X-12510--2-aminooctanoic acid levels | GCST90243748 | 9.67e-03 |
| 7161 | Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80) | GCST90668758 | 9.66e-03 |
| 7162 | Physical decline (log-difference score) | GCST90565847 | 9.65e-03 |
| 7163 | Pulse pressure | GCST90472784 | 9.65e-03 |
| 7164 | NTF4 levels | GCST90470095 | 9.65e-03 |
| 7165 | Other and unspecified tonsillitis | FING00000954 | 9.64e-03 |
| 7166 | CD7 levels | GCST90468649 | 9.64e-03 |
| 7167 | Heart rate variability traits (RMSSD) | GCST004733 | 9.64e-03 |
| 7168 | Vascular/heart problems diagnosed by doctor - Heart attack | Medical conditions | UKBB00000897 | 9.63e-03 |
| 7169 | CAPS levels | GCST90468539 | 9.57e-03 |
| 7170 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T135 | ECGU000135 | 9.57e-03 |
| 7171 | Other disorders of cornea | FING00001022 | 9.57e-03 |
| 7172 | ERBIN/SIRT2 ratio | GCST90314696 | 9.56e-03 |
| 7173 | Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditions | UKBB00000101 | 9.56e-03 |
| 7174 | GOLM2/STC1 ratio | GCST90314952 | 9.55e-03 |
| 7175 | Phospholipid levels in very small VLDL | GCST90132659 | 9.55e-03 |
| 7176 | Total cholesterol levels | GCST90239675 | 9.53e-03 |
| 7177 | Alkaline phosphatase (UKB data field 30610) | GCST90468060 | 9.53e-03 |
| 7178 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T277 | ECGA000277 | 9.50e-03 |
| 7179 | CDH1 levels | GCST90468670 | 9.49e-03 |
| 7180 | AIFM1/SIRT2 ratio | GCST90313221 | 9.48e-03 |
| 7181 | IDP dMRI TBSS L1 Body of corpus callosum | GCST90004078 | 9.46e-03 |
| 7182 | wg lh intensity-contrast superiortemporal | GCST90003821 | 9.46e-03 |
| 7183 | Operation code - pilonidal sinus surgery (anal) | Operations | UKBB00000563 | 9.43e-03 |
| 7184 | AOC3/ITGB1 ratio | GCST90313295 | 9.42e-03 |
| 7185 | Hallux rigidus | FING00000600 | 9.42e-03 |
| 7186 | SPARC/TACC3 ratio | GCST90315872 | 9.40e-03 |
| 7187 | Height (maximum, inv-normal transformed) | GCST90475359 | 9.39e-03 |
| 7188 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T496 | ECGA000496 | 9.39e-03 |
| 7189 | ISM1 levels | GCST90469630 | 9.38e-03 |
| 7190 | Diacylglycerol (18:0_18:1) levels | GCST90024714 | 9.34e-03 |
| 7191 | Other diseases of upper respiratory tract | FING00001012 | 9.33e-03 |
| 7192 | PTH levels | GCST90470372 | 9.33e-03 |
| 7193 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T81 | ECGU000081 | 9.32e-03 |
| 7194 | CELA3A/CPB1 ratio | GCST90314010 | 9.31e-03 |
| 7195 | PLAUR/TREM2 ratio | GCST90315676 | 9.30e-03 |
| 7196 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T48 | ECGA000048 | 9.30e-03 |
| 7197 | LSP1/NADK ratio | GCST90315331 | 9.27e-03 |
| 7198 | TGFB1 levels | GCST90470843 | 9.26e-03 |
| 7199 | Spleen iron concentration | GCST90101831 | 9.26e-03 |
| 7200 | Dimethylglycine levels | GCST90200424 | 9.25e-03 |
| 7201 | Statin medication | FING00001331 | 9.24e-03 |
| 7202 | Hammer toe (acquired) (PheCode 735.21) | GCST90476250 | 9.24e-03 |
| 7203 | ANG/F9 ratio | GCST90313259 | 9.23e-03 |
| 7204 | What is your height? (cm, inv-normal transformed) | GCST90475368 | 9.21e-03 |
| 7205 | ASGR1/DCBLD2 ratio | GCST90313364 | 9.20e-03 |
| 7206 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T19 | ECGA000019 | 9.20e-03 |
| 7207 | CCN3 levels | GCST90242492 | 9.20e-03 |
| 7208 | rfMRI connectivity (ICA100 edge 951) | GCST90005804 | 9.19e-03 |
| 7209 | Acute peritonitis | FING00000028 | 9.18e-03 |
| 7210 | 5alpha-androstan-3beta,17beta-diol monosulfate (2) levels | GCST90199855 | 9.18e-03 |
| 7211 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T248 | ECGA000248 | 9.16e-03 |
| 7212 | LGALS4/TIE1 ratio | GCST90315316 | 9.15e-03 |
| 7213 | Other arthritis (FG) | FING00000964 | 9.14e-03 |
| 7214 | GNLY/GZMA ratio | GCST90314949 | 9.13e-03 |
| 7215 | Phosphate levels | GCST90200393 | 9.09e-03 |
| 7216 | TNFRSF19 levels | GCST90470909 | 9.08e-03 |
| 7217 | DBNL/HEXIM1 ratio | GCST90314417 | 9.07e-03 |
| 7218 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T7 | ECGA000007 | 9.05e-03 |
| 7219 | T1 FreeSurfer BA lh BA2 exvivo volume | GCST90385534 | 9.04e-03 |
| 7220 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T46 | ECGA000046 | 9.04e-03 |
| 7221 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T45 | ECGA000045 | 9.04e-03 |
| 7222 | Operation code - cholecystectomy/gall bladder removal | Operations | UKBB00000554 | 9.03e-03 |
| 7223 | UBE2L6 levels | GCST90471001 | 9.03e-03 |
| 7224 | KIFBP/TBC1D23 ratio | GCST90315250 | 9.02e-03 |
| 7225 | CPA2/ITGB7 ratio | GCST90314207 | 9.02e-03 |
| 7226 | PAMR1 levels | GCST90470155 | 9.01e-03 |
| 7227 | Urine taurocholenate sulfate* levels in chronic kidney disease | GCST90266041 | 9.01e-03 |
| 7228 | Appendicular lean mass | GCST90000026 | 9.01e-03 |
| 7229 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T49 | ECGA000049 | 9.00e-03 |
| 7230 | 2,3-dihydroxy-5-methylthio-4-pentenoate (dmtpa) levels | GCST90200233 | 8.99e-03 |
| 7231 | lymphocyte (absolute count, maximum, inv-norm transformed) | GCST90475423 | 8.97e-03 |
| 7232 | TNC levels | GCST90470895 | 8.95e-03 |
| 7233 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T262 | ECGU000262 | 8.95e-03 |
| 7234 | RET levels | GCST90470458 | 8.94e-03 |
| 7235 | CA13/TIA1 ratio | GCST90313567 | 8.93e-03 |
| 7236 | Waist circumference adjusted for body mass index | GCST90302892 | 8.93e-03 |
| 7237 | Androstenediol (3beta,17beta) disulfate (1) levels | GCST90199842 | 8.91e-03 |
| 7238 | aparc-DKTatlas lh volume rostralmiddlefrontal | GCST90002887 | 8.91e-03 |
| 7239 | FKBP5/ZBTB16 ratio | GCST90314850 | 8.91e-03 |
| 7240 | Seminoma of testis, excluding all cancers (controls excluding all cancers) | FING00001289 | 8.90e-03 |
| 7241 | T1 FreeSurfer DK rh lingual area | GCST90385701 | 8.88e-03 |
| 7242 | SDHB levels | GCST90470561 | 8.88e-03 |
| 7243 | BCAM/ICAM4 ratio | GCST90313472 | 8.87e-03 |
| 7244 | Free cholesterol in small LDL | GCST90499617 | 8.87e-03 |
| 7245 | Takes medication for enlarged prostate (Benign prostatic hyperplasia)? | GCST90475262 | 8.86e-03 |
| 7246 | CRISP2 levels | GCST90468865 | 8.86e-03 |
| 7247 | X-26109 levels | GCST90200671 | 8.85e-03 |
| 7248 | ERBIN/LYN ratio | GCST90314694 | 8.85e-03 |
| 7249 | Triglyceride levels in very small VLDL | GCST90132669 | 8.84e-03 |
| 7250 | Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers) | FING00000770 | 8.83e-03 |
| 7251 | CLEC4G/LGALS4 ratio | GCST90314120 | 8.83e-03 |
| 7252 | VSTM2B levels | GCST90471056 | 8.82e-03 |
| 7253 | Cholesterol levels in very large VLDL | GCST90500518 | 8.82e-03 |
| 7254 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502173 | 8.81e-03 |
| 7255 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T152 | ECGU000152 | 8.81e-03 |
| 7256 | Eye conditions (confirmatory factor analysis Factor 25) | GCST90309359 | 8.80e-03 |
| 7257 | Free Cholesterol to Total Lipids in Medium HDL percentage | GCST90498583 | 8.78e-03 |
| 7258 | SEL1L levels | GCST90470564 | 8.77e-03 |
| 7259 | Pulse pressure | GCST90472783 | 8.77e-03 |
| 7260 | Takes medication for Glaucoma? | GCST90475384 | 8.76e-03 |
| 7261 | Left ventricular outflow tract obstruction, narrow definition | FING00000718 | 8.73e-03 |
| 7262 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4) | GCST90320823 | 8.72e-03 |
| 7263 | MYBPC1 levels | GCST90469969 | 8.72e-03 |
| 7264 | CERT/PRTFDC1 ratio | GCST90314029 | 8.71e-03 |
| 7265 | IDO1 levels | GCST90241490 | 8.71e-03 |
| 7266 | MCEE levels | GCST90469871 | 8.70e-03 |
| 7267 | Effects radiation NOS (PheCode 990) | GCST90476293 | 8.70e-03 |
| 7268 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T131 | ECGA000131 | 8.69e-03 |
| 7269 | QDPR levels | GCST90470400 | 8.69e-03 |
| 7270 | DTI autoptx L3 ifo r tract | GCST90385206 | 8.69e-03 |
| 7271 | ASGR1 levels | GCST90468375 | 8.68e-03 |
| 7272 | Deaf mutism, not elsewhere classified | FING00000378 | 8.67e-03 |
| 7273 | PAEP/RSPO1 ratio | GCST90315593 | 8.65e-03 |
| 7274 | TREM2 levels | GCST90470960 | 8.65e-03 |
| 7275 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T217 | ECGU000217 | 8.63e-03 |
| 7276 | IDP dMRI TBSS MD Pontine crossing tract | GCST90004028 | 8.63e-03 |
| 7277 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T147 | ECGU000147 | 8.63e-03 |
| 7278 | GRHPR levels | GCST90469400 | 8.62e-03 |
| 7279 | 2s,3R-dihydroxybutyrate levels | GCST90199882 | 8.62e-03 |
| 7280 | VWC2 levels | GCST90471064 | 8.62e-03 |
| 7281 | SERPINB13 levels | GCST90423326 | 8.62e-03 |
| 7282 | Biological Grandparent (paternal): Diabetes / Sugar | GCST90475549 | 8.60e-03 |
| 7283 | Serum 25-Hydroxyvitamin D levels | GCST90000614 | 8.59e-03 |
| 7284 | CAPN3 levels | GCST90468538 | 8.59e-03 |
| 7285 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T137 | ECGA000137 | 8.57e-03 |
| 7286 | Lysoalkylphosphatidylcholine (O-24:1) levels | GCST90024813 | 8.56e-03 |
| 7287 | FKBP4/SIRT2 ratio | GCST90314841 | 8.53e-03 |
| 7288 | CXCL9 levels | GCST90274784 | 8.53e-03 |
| 7289 | Plasma propionylcarnitine (C3) levels in chronic kidney disease | GCST90265876 | 8.51e-03 |
| 7290 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 23) | GCST90320842 | 8.51e-03 |
| 7291 | CD164/PARK7 ratio | GCST90313743 | 8.50e-03 |
| 7292 | Volume of right anterior amygdaloid area | GCST90475000 | 8.47e-03 |
| 7293 | Mean reticulocyte volume | Blood count | UKBB00000451 | 8.44e-03 |
| 7294 | Fasciitis (PheCode 728.7) | GCST90476244 | 8.42e-03 |
| 7295 | CRTAM/TNFRSF9 ratio | GCST90314280 | 8.41e-03 |
| 7296 | chloride (maximum, inv-norm transformed) | GCST90475192 | 8.40e-03 |
| 7297 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T214 | ECGA000214 | 8.38e-03 |
| 7298 | C4BPB levels | GCST90468499 | 8.38e-03 |
| 7299 | Meniscus derangement | FING00000807 | 8.38e-03 |
| 7300 | Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levels | GCST90060298 | 8.37e-03 |
| 7301 | IL6ST/PDGFRA ratio | GCST90315169 | 8.36e-03 |
| 7302 | HAVCR2/TREM2 ratio | GCST90315031 | 8.36e-03 |
| 7303 | IDP dMRI TBSS MD Uncinate fasciculus R | GCST90004071 | 8.35e-03 |
| 7304 | TXN levels | GCST90470995 | 8.34e-03 |
| 7305 | MMP10 levels | GCST90012050 | 8.33e-03 |
| 7306 | Non-seminoma of testis, excluding all cancers (controls excluding all cancers) | FING00000874 | 8.33e-03 |
| 7307 | ARHGAP30 levels | GCST90468354 | 8.33e-03 |
| 7308 | Esophageal adenocarcinoma | GCST003739 | 8.32e-03 |
| 7309 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T27 | ECGA000027 | 8.30e-03 |
| 7310 | CCL17/PDGFB ratio | GCST90313688 | 8.28e-03 |
| 7311 | SPINK1 levels | GCST90470721 | 8.27e-03 |
| 7312 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T173 | ECGA000173 | 8.25e-03 |
| 7313 | Mean reticulocyte volume (UKB data field 30260) | GCST90468088 | 8.23e-03 |
| 7314 | Wegener granulomatosis | FING00001446 | 8.23e-03 |
| 7315 | Major coronary heart disease event | FING00000746 | 8.22e-03 |
| 7316 | SCARA5/SCARF2 ratio | GCST90315808 | 8.21e-03 |
| 7317 | IDP dMRI ProbtrackX ISOVF unc l | GCST90004550 | 8.21e-03 |
| 7318 | Selective deficiency of immunoglobulin G [IgG] subclasses | FING00001288 | 8.19e-03 |
| 7319 | Creatinine levels | GCST90025946 | 8.19e-03 |
| 7320 | CA5A/GSTA1 ratio | GCST90313591 | 8.19e-03 |
| 7321 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T264 | ECGA000264 | 8.16e-03 |
| 7322 | Skin cancer | neoplasms | UKBB00000772 | 8.16e-03 |
| 7323 | GM1 ganglioside (d18:1/16:0) levels | GCST90024724 | 8.15e-03 |
| 7324 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T177 | ECGA000177 | 8.14e-03 |
| 7325 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T477 | ECGU000477 | 8.13e-03 |
| 7326 | PEAR1 levels | GCST90470204 | 8.11e-03 |
| 7327 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T178 | ECGA000178 | 8.11e-03 |
| 7328 | DAG1/MGLL ratio | GCST90314377 | 8.11e-03 |
| 7329 | ABL1/CC2D1A ratio | GCST90313148 | 8.11e-03 |
| 7330 | DTI TBSS MD Superior corona radiata L | GCST90384597 | 8.10e-03 |
| 7331 | X-12844 levels | GCST90200523 | 8.10e-03 |
| 7332 | T1 FreeSurfer pial rh posteriorcingulate area | GCST90385844 | 8.10e-03 |
| 7333 | HBB levels | GCST90025969 | 8.10e-03 |
| 7334 | Concentration of HDL particles (UKB data field 23430) | GCST90269527 | 8.10e-03 |
| 7335 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T249 | ECGA000249 | 8.10e-03 |
| 7336 | PEAR1/SCARF1 ratio | GCST90315642 | 8.08e-03 |
| 7337 | ADAM23 levels | GCST90468219 | 8.07e-03 |
| 7338 | Diverticular disease of intestine | Other diseases of intestines | UKBB00000189 | 8.07e-03 |
| 7339 | DTI TBSS L2 Anterior corona radiata R | GCST90384498 | 8.04e-03 |
| 7340 | Pulse pressure | GCST90310296 | 8.03e-03 |
| 7341 | Triglycerides in small LDL | GCST90499712 | 8.02e-03 |
| 7342 | JAM2/TNFRSF14 ratio | GCST90315240 | 8.00e-03 |
| 7343 | GGT1 levels | GCST90469336 | 8.00e-03 |
| 7344 | FABP9 levels | GCST90469179 | 7.98e-03 |
| 7345 | FAM3B/GUCA2A ratio | GCST90314779 | 7.98e-03 |
| 7346 | IDP dMRI ProbtrackX OD str l | GCST90004473 | 7.98e-03 |
| 7347 | Volume of left central nucleus | GCST90474883 | 7.97e-03 |
| 7348 | B4GALT1/B4GAT1 ratio | GCST90313429 | 7.97e-03 |
| 7349 | Indolebutyrate levels | GCST90199759 | 7.97e-03 |
| 7350 | GLOD4/MIF ratio | GCST90314939 | 7.96e-03 |
| 7351 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54) | GCST90320617 | 7.96e-03 |
| 7352 | KITLG levels | GCST90012023 | 7.95e-03 |
| 7353 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T261 | ECGU000261 | 7.95e-03 |
| 7354 | IGSF9 levels | GCST90469541 | 7.95e-03 |
| 7355 | Eosinophil percentage of granulocytes | GCST004617 | 7.94e-03 |
| 7356 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T148 | ECGA000148 | 7.92e-03 |
| 7357 | AP1G2 levels | GCST90468323 | 7.92e-03 |
| 7358 | SIRPA levels | GCST90470639 | 7.92e-03 |
| 7359 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T206 | ECGA000206 | 7.92e-03 |
| 7360 | CCL17/THPO ratio | GCST90313689 | 7.91e-03 |
| 7361 | Chronic obstructive pulmonary disease x ever smoker interaction (main effect) | GCST90016586 | 7.91e-03 |
| 7362 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T469 | ECGU000469 | 7.90e-03 |
| 7363 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78) | GCST90320897 | 7.89e-03 |
| 7364 | NCR1 levels | GCST90090153 | 7.87e-03 |
| 7365 | CDH2/CDHR2 ratio | GCST90313950 | 7.83e-03 |
| 7366 | Plasma pregnenetriol disulfate* levels in chronic kidney disease | GCST90265864 | 7.82e-03 |
| 7367 | Prescriptions - doxazosin | alpha1-antagonist,alpha blocker | UKBB00000679 | 7.79e-03 |
| 7368 | VTI1A levels | GCST90471060 | 7.78e-03 |
| 7369 | Excessive vomiting in pregnancy | FING00000523 | 7.77e-03 |
| 7370 | wg lh intensity-contrast pericalcarine | GCST90003812 | 7.75e-03 |
| 7371 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 33) | GCST90320596 | 7.75e-03 |
| 7372 | VGF levels | GCST90471038 | 7.73e-03 |
| 7373 | Lysophosphatidylcholine (24:0) [sn2] levels | GCST90024187 | 7.71e-03 |
| 7374 | AIFM1/EGF ratio | GCST90313219 | 7.68e-03 |
| 7375 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T21 | ECGU000021 | 7.68e-03 |
| 7376 | RILP/RWDD1 ratio | GCST90315778 | 7.66e-03 |
| 7377 | SIGLEC8 levels | GCST90089886 | 7.65e-03 |
| 7378 | Nasal polyps | GCST90468143 | 7.64e-03 |
| 7379 | Hypertrophic scar | FING00000642 | 7.62e-03 |
| 7380 | EGFR/MEGF9 ratio | GCST90314614 | 7.61e-03 |
| 7381 | Thyrotoxicosis with diffuse goitre | FING00001361 | 7.60e-03 |
| 7382 | APBB1IP/POLR2F ratio | GCST90313300 | 7.60e-03 |
| 7383 | IDP dMRI TBSS ISOVF Cingulum cingulate gyrus R | GCST90004511 | 7.60e-03 |
| 7384 | Creatinine levels in bottom 99% of individuals by creatinine levels | GCST90566733 | 7.59e-03 |
| 7385 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T152 | ECGA000152 | 7.57e-03 |
| 7386 | FKBP4 levels | GCST90469243 | 7.57e-03 |
| 7387 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T274 | ECGA000274 | 7.56e-03 |
| 7388 | AmygNuclei lh volume Central-nucleus | GCST90002652 | 7.56e-03 |
| 7389 | Triglycerides in LDL (UKB data field 23409) | GCST90269506 | 7.56e-03 |
| 7390 | Operative procedures - Endoscopic resection of semilunar cartilage NEC | Summary Operations | UKBB00000577 | 7.56e-03 |
| 7391 | X-12063 levels | GCST90243687 | 7.55e-03 |
| 7392 | CLMP/GFRA1 ratio | GCST90314133 | 7.55e-03 |
| 7393 | Propionylglycine levels | GCST90199705 | 7.54e-03 |
| 7394 | Omega-6 fatty acids levels (UKB data field 23445) | GCST90269542 | 7.53e-03 |
| 7395 | IL15/NCR1 ratio | GCST90315150 | 7.53e-03 |
| 7396 | CTSL levels | GCST90468914 | 7.53e-03 |
| 7397 | Other disorders of eye and adnexa | FING00001025 | 7.53e-03 |
| 7398 | TMPRSS15 levels | GCST90470892 | 7.52e-03 |
| 7399 | SMPD1/SMPDL3A ratio | GCST90315854 | 7.51e-03 |
| 7400 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T14 | ECGA000014 | 7.51e-03 |
| 7401 | LCN2/PRTN3 ratio | GCST90315307 | 7.51e-03 |
| 7402 | VLDL cholesterol levels | GCST90500189 | 7.49e-03 |
| 7403 | PRKG1 levels | GCST90470330 | 7.49e-03 |
| 7404 | IDP dMRI TBSS L1 Corticospinal tract R | GCST90004081 | 7.49e-03 |
| 7405 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T213 | ECGA000213 | 7.49e-03 |
| 7406 | IL5RA levels | GCST90469600 | 7.49e-03 |
| 7407 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T20 | ECGU000020 | 7.48e-03 |
| 7408 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121) | GCST90320684 | 7.46e-03 |
| 7409 | CX3CL1/DSG2 ratio | GCST90314323 | 7.46e-03 |
| 7410 | SERPINE1/SPARC ratio | GCST90315834 | 7.46e-03 |
| 7411 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T142 | ECGU000142 | 7.45e-03 |
| 7412 | aparc-Desikan rh volume fusiform | GCST90002807 | 7.44e-03 |
| 7413 | EDAR/PSRC1 ratio | GCST90314584 | 7.42e-03 |
| 7414 | Neutrophil count | GCST90018748 | 7.42e-03 |
| 7415 | CGREF1/FAM3C ratio | GCST90314032 | 7.42e-03 |
| 7416 | Operation code - haemorroidectomy / piles surgery/ banding of piles | Operations | UKBB00000557 | 7.42e-03 |
| 7417 | Triglyceride levels in chylomicrons and extremely large VLDL | GCST90501068 | 7.41e-03 |
| 7418 | Polymyalgia rheumatica | FING00001188 | 7.40e-03 |
| 7419 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T184 | ECGA000184 | 7.40e-03 |
| 7420 | DAPK2 levels | GCST90468945 | 7.38e-03 |
| 7421 | Diastolic blood pressure (BMI adjusted) | GCST90335165 | 7.38e-03 |
| 7422 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T230 | ECGU000230 | 7.37e-03 |
| 7423 | T1 FreeSurfer aseg 3rd-Ventricle | GCST90384147 | 7.36e-03 |
| 7424 | creatinine (mean, inv-norm transformed) | GCST90475229 | 7.36e-03 |
| 7425 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T80 | ECGU000080 | 7.36e-03 |
| 7426 | chloride (mean, inv-norm transformed) | GCST90475194 | 7.36e-03 |
| 7427 | FAS levels | GCST90090701 | 7.35e-03 |
| 7428 | Zoster infection | GCST90018721 | 7.35e-03 |
| 7429 | Breast cancer | GCST90429846 | 7.33e-03 |
| 7430 | RASSF2 levels | GCST90470431 | 7.32e-03 |
| 7431 | CRYBB1 levels | GCST90468874 | 7.31e-03 |
| 7432 | DNAJB1/SIRT2 ratio | GCST90314511 | 7.31e-03 |
| 7433 | Birth weight | Early life factors | UKBB00000095 | 7.31e-03 |
| 7434 | estimated glomerular filtration rate (eGFR, minimum, inv-norm transformed) | GCST90475285 | 7.29e-03 |
| 7435 | Mean reticulocyte volume | GCST90002396 | 7.28e-03 |
| 7436 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T180 | ECGA000180 | 7.27e-03 |
| 7437 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T11 | ECGU000011 | 7.27e-03 |
| 7438 | height (minimum, inv-normal transformed) | GCST90475365 | 7.27e-03 |
| 7439 | Triacylglycerol_45:4_[M+NH4]1+ levels | GCST90060333 | 7.26e-03 |
| 7440 | Calculus of kidney and ureter | FING00000236 | 7.26e-03 |
| 7441 | C5 levels | GCST90468500 | 7.26e-03 |
| 7442 | Mixed conductive and sensorineural hearing loss | FING00000827 | 7.25e-03 |
| 7443 | wg rh intensity-contrast insula | GCST90003861 | 7.23e-03 |
| 7444 | IRF2 levels | GCST90241566 | 7.20e-03 |
| 7445 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125) | GCST90320688 | 7.19e-03 |
| 7446 | Total fatty acids levels (UKB data field 23442) | GCST90269539 | 7.19e-03 |
| 7447 | Cancer (standard GWA) | GCST90267270 | 7.19e-03 |
| 7448 | COL18A1/RETN ratio | GCST90314170 | 7.18e-03 |
| 7449 | HSPA1A/MGLL ratio | GCST90315083 | 7.18e-03 |
| 7450 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T185 | ECGA000185 | 7.18e-03 |
| 7451 | Migraine without aura and triptan purchases | FING00000822 | 7.17e-03 |
| 7452 | Torso length to body height ratio | GCST90270262 | 7.16e-03 |
| 7453 | HSPG2 levels | GCST90179392 | 7.15e-03 |
| 7454 | HLA-DMA levels | GCST90241448 | 7.15e-03 |
| 7455 | Eicosenoylcarnitine (C20:1) levels | GCST90200148 | 7.14e-03 |
| 7456 | FXYD5/TMSB10 ratio | GCST90314906 | 7.14e-03 |
| 7457 | Gout | GCST90399700 | 7.14e-03 |
| 7458 | wg rh intensity-contrast medialorbitofrontal | GCST90003840 | 7.13e-03 |
| 7459 | ESAM/TGFB1 ratio | GCST90314718 | 7.10e-03 |
| 7460 | Phosphatidylcholine-O_40:6_[M+H]1+/Phosphatidylcholine-P_40:5_[M+H]1+ levels | GCST90060420 | 7.09e-03 |
| 7461 | Gouty arthropathy (PheCode 274.11) | GCST90475738 | 7.09e-03 |
| 7462 | Aplastic anemia (PheCode 284) | GCST90475783 | 7.08e-03 |
| 7463 | Eye problems/disorders - Glaucoma | Eyesight | UKBB00000231 | 7.08e-03 |
| 7464 | rfMRI connectivity (ICA100 edge 399) | GCST90005252 | 7.05e-03 |
| 7465 | CD58/LTBR ratio | GCST90313851 | 7.04e-03 |
| 7466 | Unstable angina pectoris | FING00001405 | 7.04e-03 |
| 7467 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T18 | ECGA000018 | 7.03e-03 |
| 7468 | CES2 levels | GCST90468719 | 7.02e-03 |
| 7469 | Monounsaturated fatty acid levels | GCST90502363 | 7.02e-03 |
| 7470 | Prostate cancer | GCST90475185 | 7.00e-03 |
| 7471 | CNTN1/EGFR ratio | GCST90314162 | 7.00e-03 |
| 7472 | estimated glomerular filtration rate (eGFR, mean, inv-norm transformed) | GCST90475282 | 7.00e-03 |
| 7473 | CD4/LILRB4 ratio | GCST90313843 | 6.99e-03 |
| 7474 | Massiliomicrobiota abundance in stool | GCST90032470 | 6.98e-03 |
| 7475 | aparc-Desikan lh area fusiform | GCST90003079 | 6.98e-03 |
| 7476 | Lung function (FVC) | GCST90025998 | 6.97e-03 |
| 7477 | BCAN/MOG ratio | GCST90313480 | 6.97e-03 |
| 7478 | Atopic dermatitis | GCST90018564 | 6.97e-03 |
| 7479 | IFNGR1 levels | GCST90469513 | 6.97e-03 |
| 7480 | SLC39A14 levels | GCST90470660 | 6.97e-03 |
| 7481 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 58) | GCST90320621 | 6.96e-03 |
| 7482 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T263 | ECGA000263 | 6.95e-03 |
| 7483 | CKMB levels | GCST90475221 | 6.92e-03 |
| 7484 | PLA2G15 levels | GCST90470245 | 6.89e-03 |
| 7485 | BMP7 levels | GCST90088157 | 6.89e-03 |
| 7486 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65) | GCST90320628 | 6.89e-03 |
| 7487 | Central corneal thickness | GCST006366 | 6.87e-03 |
| 7488 | YWHAQ levels | GCST90471092 | 6.87e-03 |
| 7489 | APCS levels | GCST90468328 | 6.87e-03 |
| 7490 | X-08402 levels | GCST90243538 | 6.86e-03 |
| 7491 | aparc-a2009s rh volume G-precentral | GCST90003027 | 6.86e-03 |
| 7492 | TFPI levels | GCST90470839 | 6.86e-03 |
| 7493 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T256 | ECGA000256 | 6.86e-03 |
| 7494 | HNRNPK/USP8 ratio | GCST90315070 | 6.85e-03 |
| 7495 | KITLG levels | GCST90274833 | 6.84e-03 |
| 7496 | Cancer of bronchus; lung (PheCode 165.1) | GCST90475573 | 6.83e-03 |
| 7497 | HippSubfield rh volume CA3-head | GCST90002707 | 6.82e-03 |
| 7498 | CD79B/FCRL2 ratio | GCST90313900 | 6.82e-03 |
| 7499 | IDP SWI T2star right caudate | GCST90003866 | 6.81e-03 |
| 7500 | Lateral epicondylitis | FING00000715 | 6.80e-03 |
| 7501 | IDP dMRI ProbtrackX L2 ar r | GCST90004274 | 6.80e-03 |
| 7502 | Thyroid cancer (PheCode 193) | GCST90475600 | 6.79e-03 |
| 7503 | Nontoxic nodular goiter (PheCode 241) | GCST90475638 | 6.79e-03 |
| 7504 | NAP1L4 levels | GCST90469998 | 6.78e-03 |
| 7505 | Autoimmune diseases excluding thyroid diseases | FING00000132 | 6.78e-03 |
| 7506 | ARHGAP25 levels | GCST90242651 | 6.78e-03 |
| 7507 | CEACAM8/RNASE3 ratio | GCST90314004 | 6.78e-03 |
| 7508 | SORD levels | GCST90470709 | 6.77e-03 |
| 7509 | 1-stearoyl-2-docosahexaenoyl-gpc (18:0/22:6) levels | GCST90200046 | 6.77e-03 |
| 7510 | CEACAM20 levels | GCST90468693 | 6.77e-03 |
| 7511 | TARBP2 levels | GCST90470805 | 6.77e-03 |
| 7512 | Creatinine | Blood biochemistry | UKBB00000156 | 6.74e-03 |
| 7513 | Total Lipids in HDL | GCST90497401 | 6.74e-03 |
| 7514 | CCL19 levels | GCST90274765 | 6.73e-03 |
| 7515 | Diabetes (confirmatory factor analysis Factor 28) | GCST90309362 | 6.73e-03 |
| 7516 | Hearing difficulty | GCST90245774 | 6.73e-03 |
| 7517 | Prescriptions - thyroid hormone | hormone | UKBB00000705 | 6.73e-03 |
| 7518 | Prescriptions - levothyroxine | thyroid hormone | UKBB00000687 | 6.72e-03 |
| 7519 | CBLN4/RET ratio | GCST90313660 | 6.71e-03 |
| 7520 | IFIT2 levels | GCST90090864 | 6.70e-03 |
| 7521 | Estimated glomerular filtration rate (creatinine, cystatin c) | GCST90428446 | 6.68e-03 |
| 7522 | Other intervertebral disc disorders | FING00001063 | 6.65e-03 |
| 7523 | aparc-DKTatlas lh volume cuneus | GCST90002865 | 6.63e-03 |
| 7524 | Left-hemisphere salience/ventral attention network to pallidum white-matter structural connectivity | GCST90302722 | 6.62e-03 |
| 7525 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T136 | ECGA000136 | 6.61e-03 |
| 7526 | CKAP2 levels | GCST90240866 | 6.61e-03 |
| 7527 | Hematocrit | GCST90002305 | 6.60e-03 |
| 7528 | CDH5/PEAR1 ratio | GCST90313959 | 6.58e-03 |
| 7529 | EPS8L2/LGALS4 ratio | GCST90314685 | 6.58e-03 |
| 7530 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T132 | ECGA000132 | 6.57e-03 |
| 7531 | CST3 levels | GCST90468894 | 6.55e-03 |
| 7532 | wg lh intensity-contrast parahippocampal | GCST90003807 | 6.55e-03 |
| 7533 | NHLRC3 levels | GCST90470046 | 6.52e-03 |
| 7534 | HPCAL1/SERPINB9 ratio | GCST90315079 | 6.51e-03 |
| 7535 | Left ventricular end diastole anterospetal wall thickness | GCST90278519 | 6.51e-03 |
| 7536 | DTI TBSS FA Anterior corona radiata L | GCST90384403 | 6.50e-03 |
| 7537 | aparc-pial lh area pericalcarine | GCST90003161 | 6.48e-03 |
| 7538 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T51 | ECGA000051 | 6.48e-03 |
| 7539 | APOB/APOA1 ratio | GCST90269538 | 6.48e-03 |
| 7540 | MICB or MICA levels | GCST90469905 | 6.46e-03 |
| 7541 | Operation code - anterior/posterior repair bladder/uterus | Operations | UKBB00000548 | 6.46e-03 |
| 7542 | N-acetylmethionine levels | GCST90200289 | 6.46e-03 |
| 7543 | Gestational diabetes mellitus | GCST90566419 | 6.46e-03 |
| 7544 | Ovarian dysfunction | FING00001133 | 6.45e-03 |
| 7545 | APOA1 levels | GCST90497119 | 6.44e-03 |
| 7546 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T278 | ECGA000278 | 6.44e-03 |
| 7547 | Serum 25-Hydroxyvitamin D levels | GCST90000618 | 6.43e-03 |
| 7548 | CASP7 levels | GCST90468547 | 6.43e-03 |
| 7549 | PDGF-BB levels | GCST90428430 | 6.42e-03 |
| 7550 | Intrahepatic cholestasis of pregnancy | GCST90454199 | 6.40e-03 |
| 7551 | Systemic lupus erythematosus | GCST90011866 | 6.39e-03 |
| 7552 | Concentration of medium VLDL particles | GCST90499017 | 6.39e-03 |
| 7553 | IDP dMRI TBSS L1 Posterior corona radiata L | GCST90004102 | 6.39e-03 |
| 7554 | Phospholipids to Total Lipids in Medium VLDL percentage | GCST90499044 | 6.39e-03 |
| 7555 | ENG/PEAR1 ratio | GCST90314649 | 6.39e-03 |
| 7556 | Perforation of tympanic membrane | FING00001155 | 6.37e-03 |
| 7557 | Angina | GCST90468109 | 6.36e-03 |
| 7558 | KLK15 levels | GCST90469701 | 6.35e-03 |
| 7559 | EPHB6/VWC2 ratio | GCST90314683 | 6.34e-03 |
| 7560 | Retinal arteriolar width | GCST90270398 | 6.34e-03 |
| 7561 | CTSZ/HSPG2 ratio | GCST90314318 | 6.34e-03 |
| 7562 | HippSubfield lh volume GC-ML-DG-head | GCST90002679 | 6.33e-03 |
| 7563 | Rheumatoid arthritis | GCST90132224 | 6.33e-03 |
| 7564 | Oral glucose tolerance test-2h | GCST90297790 | 6.33e-03 |
| 7565 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T50 | ECGA000050 | 6.29e-03 |
| 7566 | FYB1/PPP1R12A ratio | GCST90314913 | 6.28e-03 |
| 7567 | MANF/PTPN6 ratio | GCST90315366 | 6.27e-03 |
| 7568 | FST levels | GCST90012080 | 6.27e-03 |
| 7569 | Right-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302788 | 6.27e-03 |
| 7570 | AXL/IL18BP ratio | GCST90313420 | 6.27e-03 |
| 7571 | S100A11/S100A12 ratio | GCST90315798 | 6.26e-03 |
| 7572 | CDH6/NTRK2 ratio | GCST90313962 | 6.26e-03 |
| 7573 | CEACAM1 levels | GCST90468692 | 6.25e-03 |
| 7574 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T153 | ECGA000153 | 6.25e-03 |
| 7575 | aparc-DKTatlas rh volume fusiform | GCST90002898 | 6.24e-03 |
| 7576 | CTRC/KIRREL2 ratio | GCST90314309 | 6.23e-03 |
| 7577 | Total fatty acid levels | GCST90502220 | 6.23e-03 |
| 7578 | CDCP1/IL18BP ratio | GCST90313937 | 6.23e-03 |
| 7579 | SEPTIN8 levels | GCST90470578 | 6.21e-03 |
| 7580 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502160 | 6.21e-03 |
| 7581 | Plasma taurocholenate sulfate* levels in chronic kidney disease | GCST90266040 | 6.21e-03 |
| 7582 | CD2AP levels | GCST90468617 | 6.20e-03 |
| 7583 | Volume of left whole amygdala | GCST90474898 | 6.18e-03 |
| 7584 | MAP2K6/MGMT ratio | GCST90315373 | 6.18e-03 |
| 7585 | MAP4K5/STAMBP ratio | GCST90315382 | 6.16e-03 |
| 7586 | Phospholipids in HDL | GCST90497430 | 6.15e-03 |
| 7587 | Free cholesterol in large LDL | GCST90497987 | 6.15e-03 |
| 7588 | aparc-Desikan lh area parstriangularis | GCST90003092 | 6.14e-03 |
| 7589 | F2R/TNFRSF14 ratio | GCST90314739 | 6.14e-03 |
| 7590 | DTI autoptx L2 ilf r tract | GCST90385181 | 6.14e-03 |
| 7591 | Cerebral aneurysm, nonruptured | FING00000263 | 6.13e-03 |
| 7592 | PADI2 levels | GCST90470142 | 6.12e-03 |
| 7593 | Left-hemisphere visual network to right-hemisphere visual network white-matter structural connectivity | GCST90302655 | 6.12e-03 |
| 7594 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T30 | ECGA000030 | 6.11e-03 |
| 7595 | Polyunsaturated fatty acids levels (UKB data field 23446) | GCST90269543 | 6.11e-03 |
| 7596 | Diverticulitis | GCST90468125 | 6.11e-03 |
| 7597 | Volume of left paralaminar nucleus | GCST90474985 | 6.10e-03 |
| 7598 | Congenital lactase deficiency | FING00000329 | 6.10e-03 |
| 7599 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T4 | ECGA000004 | 6.10e-03 |
| 7600 | CALCOCO1/VPS53 ratio | GCST90313612 | 6.09e-03 |
| 7601 | PPCDC levels | GCST90470290 | 6.09e-03 |
| 7602 | CAMKK1/FOXO1 ratio | GCST90313613 | 6.07e-03 |
| 7603 | AZU1/RNASE3 ratio | GCST90313428 | 6.06e-03 |
| 7604 | MED18/TACC3 ratio | GCST90315414 | 6.06e-03 |
| 7605 | Cholesteryl Esters in Medium HDL | GCST90498538 | 6.06e-03 |
| 7606 | DNAJB14 levels | GCST90240952 | 6.05e-03 |
| 7607 | REST UKBBICA NODEamps25 0021 | GCST90385504 | 6.05e-03 |
| 7608 | Linoleic acid levels | GCST90502010 | 6.03e-03 |
| 7609 | IDO1 levels | GCST90469506 | 6.02e-03 |
| 7610 | CEACAM8/MMP9 ratio | GCST90314002 | 6.02e-03 |
| 7611 | Treatment/medication code - ibuprofen | Medications | UKBB00000847 | 6.01e-03 |
| 7612 | rfMRI connectivity (ICA100 edge 380) | GCST90005233 | 6.01e-03 |
| 7613 | DTI autoptx L2 ilf l tract | GCST90385180 | 6.00e-03 |
| 7614 | Migraine without aura | FING00000821 | 6.00e-03 |
| 7615 | wg rh intensity-contrast lingual | GCST90003839 | 5.99e-03 |
| 7616 | Thyroid stimulating hormone levels | GCST90319321 | 5.96e-03 |
| 7617 | Corneal resistance factor (right) | Intraocular pressure | UKBB00000151 | 5.96e-03 |
| 7618 | BMPER levels | GCST90468455 | 5.95e-03 |
| 7619 | Chronic obstructive pulmonary disease in never smokers | GCST90016589 | 5.95e-03 |
| 7620 | Left-hemisphere visual network to thalamus white-matter structural connectivity | GCST90302662 | 5.95e-03 |
| 7621 | DKKL1 levels | GCST90469000 | 5.94e-03 |
| 7622 | wg rh intensity-contrast middletemporal | GCST90003841 | 5.92e-03 |
| 7623 | Humerus length to body height ratio | GCST90270259 | 5.92e-03 |
| 7624 | HVEM on Terminally Differentiated CD4+ T cell | GCST90001879 | 5.91e-03 |
| 7625 | Arthropathy in ulcerative colitis | FING00000110 | 5.90e-03 |
| 7626 | VEGFD levels | GCST90471037 | 5.90e-03 |
| 7627 | CD40LG/TNFSF14 ratio | GCST90313827 | 5.90e-03 |
| 7628 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T11 | ECGA000011 | 5.90e-03 |
| 7629 | IDP dMRI ProbtrackX ISOVF ar r | GCST90004526 | 5.90e-03 |
| 7630 | Glaucoma | sense organs | UKBB00000287 | 5.89e-03 |
| 7631 | CTSO levels | GCST90468915 | 5.89e-03 |
| 7632 | Phosphatidylcholine levels | GCST90092937 | 5.89e-03 |
| 7633 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T172 | ECGA000172 | 5.89e-03 |
| 7634 | IDP T1 FAST ROIs L intracalc cortex | GCST90002497 | 5.88e-03 |
| 7635 | MECR levels | GCST90469879 | 5.88e-03 |
| 7636 | Basal metabolic rate (UKB data field 23105) | GCST90468159 | 5.87e-03 |
| 7637 | N-acetyltaurine levels | GCST90199967 | 5.87e-03 |
| 7638 | MITD1/SNX9 ratio | GCST90315454 | 5.87e-03 |
| 7639 | ACOT13 levels | GCST90468200 | 5.87e-03 |
| 7640 | Volume of left medial nucleus | GCST90474976 | 5.85e-03 |
| 7641 | Total fatty acid levels | GCST90500053 | 5.84e-03 |
| 7642 | Operation code - inguinal/femoral hernia repair | Operations | UKBB00000561 | 5.84e-03 |
| 7643 | Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers) | FING00000756 | 5.84e-03 |
| 7644 | Other aneurysm (PheCode 442) | GCST90475992 | 5.82e-03 |
| 7645 | MMP8/TGFA ratio | GCST90315466 | 5.80e-03 |
| 7646 | ADGRD1 levels | GCST90468235 | 5.80e-03 |
| 7647 | CXCL9 levels | GCST90468935 | 5.80e-03 |
| 7648 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T185 | ECGU000185 | 5.79e-03 |
| 7649 | EDIL3 levels | GCST90469072 | 5.79e-03 |
| 7650 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T181 | ECGA000181 | 5.78e-03 |
| 7651 | PLA2G4A/PPP1R12A ratio | GCST90315666 | 5.77e-03 |
| 7652 | Heart failure with reduced EF [Systolic or combined heart failure] (PheCode 428.3) | GCST90475983 | 5.77e-03 |
| 7653 | EGF/TNFSF14 ratio | GCST90314615 | 5.77e-03 |
| 7654 | aseg lh number HolesBeforeFixing | GCST90002630 | 5.77e-03 |
| 7655 | CTRB1/KIRREL2 ratio | GCST90314306 | 5.76e-03 |
| 7656 | Carnitine levels | GCST90199621 | 5.74e-03 |
| 7657 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T83 | ECGA000083 | 5.73e-03 |
| 7658 | Hematocrit | GCST90018740 | 5.73e-03 |
| 7659 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T76 | ECGA000076 | 5.73e-03 |
| 7660 | CLEC4D/TGFA ratio | GCST90314117 | 5.71e-03 |
| 7661 | aparc-a2009s lh volume S-precentral-sup-part | GCST90002993 | 5.71e-03 |
| 7662 | IDP dMRI TBSS L1 Anterior corona radiata L | GCST90004098 | 5.71e-03 |
| 7663 | Microscopic polyangiitis | FING00000817 | 5.71e-03 |
| 7664 | DTI TBSS L2 Superior cerebellar peduncle R | GCST90384488 | 5.70e-03 |
| 7665 | Maximum indexed left atrial volume | GCST90019012 | 5.69e-03 |
| 7666 | IDP dMRI TBSS L1 Superior corona radiata R | GCST90004099 | 5.69e-03 |
| 7667 | aparc-Desikan lh volume precentral | GCST90002791 | 5.69e-03 |
| 7668 | IGBP1 levels | GCST90469521 | 5.68e-03 |
| 7669 | DBH levels | GCST90468948 | 5.68e-03 |
| 7670 | Corneal hysteresis (right) | Intraocular pressure | UKBB00000149 | 5.67e-03 |
| 7671 | CHI3L1/PRSS8 ratio | GCST90314044 | 5.65e-03 |
| 7672 | CST3 levels | UKBB00000163 | 5.63e-03 |
| 7673 | Total body bone mineral density (age 0-15) | GCST005345 | 5.63e-03 |
| 7674 | DKK1/VEGFC ratio | GCST90314484 | 5.63e-03 |
| 7675 | Adenocarcinoma and papilloma adenocarcinoma of rectum | FING00000039 | 5.62e-03 |
| 7676 | Breast cancer (triple negative or BRCA1-positive) | GCST010100 | 5.62e-03 |
| 7677 | Triglyceride (52:5) levels | GCST90488320 | 5.61e-03 |
| 7678 | PGF levels | GCST90470218 | 5.60e-03 |
| 7679 | IDP dMRI ProbtrackX OD fma | GCST90004460 | 5.60e-03 |
| 7680 | FABP4/SNCG ratio | GCST90314759 | 5.60e-03 |
| 7681 | APEX1/LSP1 ratio | GCST90313307 | 5.59e-03 |
| 7682 | USP25 levels | GCST90471019 | 5.57e-03 |
| 7683 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502571 | 5.57e-03 |
| 7684 | PPP1R9B levels | GCST90470305 | 5.57e-03 |
| 7685 | Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000812 | 5.56e-03 |
| 7686 | T1 FreeSurfer a2009s rh Pole occipital area | GCST90384931 | 5.56e-03 |
| 7687 | creatinine (minimum, inv-norm transformed) | GCST90475232 | 5.56e-03 |
| 7688 | CNST/DOK2 ratio | GCST90314157 | 5.54e-03 |
| 7689 | CRYBB2 levels | GCST90468875 | 5.54e-03 |
| 7690 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T183 | ECGA000183 | 5.54e-03 |
| 7691 | Estimated glomerular filtration rate, serum creatinine | Other measurement | UKBB00000212 | 5.52e-03 |
| 7692 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T186 | ECGA000186 | 5.51e-03 |
| 7693 | Nonsuppurative otitis media | FING00000885 | 5.51e-03 |
| 7694 | Degree of unsaturation | GCST90502233 | 5.50e-03 |
| 7695 | aparc-DKTatlas lh area cuneus | GCST90003237 | 5.50e-03 |
| 7696 | Neoplasm of uncertain behavior of skin (PheCode 173) | GCST90475585 | 5.50e-03 |
| 7697 | GP6/SCARF1 ratio | GCST90314969 | 5.50e-03 |
| 7698 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T170 | ECGA000170 | 5.49e-03 |
| 7699 | Monounsaturated fatty acid levels | GCST90502038 | 5.49e-03 |
| 7700 | Seborrheic keratosis (PheCode 702.2) | GCST90476206 | 5.49e-03 |
| 7701 | IGFBP6/SMOC2 ratio | GCST90315138 | 5.49e-03 |
| 7702 | Alanine levels | GCST90497086 | 5.48e-03 |
| 7703 | Behaviour of cancer tumour: malignant, primary site, PHESANT recoding (UKB data field 40012_3) | GCST90043946 | 5.48e-03 |
| 7704 | Triglyceride to phosphoglyceride ratio | GCST90499992 | 5.48e-03 |
| 7705 | CC2D1A/STIP1 ratio | GCST90313665 | 5.47e-03 |
| 7706 | LAYN/VWC2 ratio | GCST90315293 | 5.47e-03 |
| 7707 | Emphysema (PheCode 496.1) | GCST90476028 | 5.47e-03 |
| 7708 | Open wound of foot except toe(s) alone (PheCode 871.3) | GCST90476286 | 5.46e-03 |
| 7709 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76) | GCST90320895 | 5.45e-03 |
| 7710 | Gout, unspecified | FING00000589 | 5.43e-03 |
| 7711 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T260 | ECGU000260 | 5.43e-03 |
| 7712 | SEMA4D/TREML2 ratio | GCST90315823 | 5.42e-03 |
| 7713 | CXCL5/PPIB ratio | GCST90314352 | 5.41e-03 |
| 7714 | creatinine (maximum, inv-norm transformed) | GCST90475226 | 5.41e-03 |
| 7715 | estimated glomerular filtration rate (eGFR, maximum, inv-norm transformed) | GCST90475280 | 5.41e-03 |
| 7716 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T15 | ECGA000015 | 5.41e-03 |
| 7717 | Blood cell traits latent factor 18 (platelet) | GCST90559260 | 5.41e-03 |
| 7718 | aparc-DKTatlas lh thickness cuneus | GCST90003543 | 5.40e-03 |
| 7719 | IDP T1 FAST ROIs R hippocampus | GCST90002556 | 5.40e-03 |
| 7720 | Secondary hypertension | FING00001285 | 5.39e-03 |
| 7721 | CRHBP/TREM2 ratio | GCST90314260 | 5.37e-03 |
| 7722 | T1 FreeSurfer DK rh lateraloccipital volume | GCST90385767 | 5.36e-03 |
| 7723 | T1 CAT volume R SupramarginalGyrusanteriordivision | GCST90384037 | 5.36e-03 |
| 7724 | Creatinine levels (UKB data field 30700) | GCST90468067 | 5.35e-03 |
| 7725 | Urate | Blood biochemistry | UKBB00000884 | 5.35e-03 |
| 7726 | AHCY/FABP5 ratio | GCST90313208 | 5.35e-03 |
| 7727 | Diastolic blood pressure (BMI unadjusted) | GCST90335164 | 5.34e-03 |
| 7728 | SETMAR levels | GCST90470605 | 5.34e-03 |
| 7729 | Trihexosylcermide (d18:1/18:0) levels | GCST90024738 | 5.32e-03 |
| 7730 | Total fatty acid levels | GCST90502727 | 5.31e-03 |
| 7731 | Acetabular diameter | GCST90448906 | 5.30e-03 |
| 7732 | HippSubfield lh volume CA4-head | GCST90002682 | 5.30e-03 |
| 7733 | GP2/SELE ratio | GCST90314962 | 5.29e-03 |
| 7734 | DNAJB2 levels | GCST90469013 | 5.29e-03 |
| 7735 | AGRN levels | GCST90468255 | 5.28e-03 |
| 7736 | DTI autoptx L3 ilf r tract | GCST90385208 | 5.28e-03 |
| 7737 | Diacylglycerol_44:6_[M+H-H2O]1+ levels | GCST90060245 | 5.28e-03 |
| 7738 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T472 | ECGU000472 | 5.27e-03 |
| 7739 | Allergic rhinitis | FING00000071 | 5.26e-03 |
| 7740 | IRAG2 levels | GCST90469626 | 5.26e-03 |
| 7741 | TRIM58 levels | GCST90470969 | 5.25e-03 |
| 7742 | Right-hemisphere visual network to amygdala white-matter structural connectivity | GCST90302786 | 5.24e-03 |
| 7743 | CDKN2D/ITGB1BP2 ratio | GCST90313987 | 5.24e-03 |
| 7744 | GZMB levels | GCST90469424 | 5.23e-03 |
| 7745 | aparc-a2009s lh volume S-circular-insula-sup | GCST90002973 | 5.23e-03 |
| 7746 | BA-exvivo lh area V1 | GCST90003216 | 5.23e-03 |
| 7747 | FCRL1/TREML2 ratio | GCST90314797 | 5.22e-03 |
| 7748 | IDP SWI T2star left caudate | GCST90003865 | 5.22e-03 |
| 7749 | Serum 25-Hydroxyvitamin D levels (conditioned on BMI) | GCST90000616 | 5.21e-03 |
| 7750 | KYNU levels | GCST90469722 | 5.21e-03 |
| 7751 | Blepharochalasis | FING00000220 | 5.20e-03 |
| 7752 | Intraocular pressure (confirmatory factor analysis Factor 26) | GCST90309360 | 5.20e-03 |
| 7753 | NECTIN4/SPINK5 ratio | GCST90315534 | 5.19e-03 |
| 7754 | Keloid | GCST90018654 | 5.19e-03 |
| 7755 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502181 | 5.19e-03 |
| 7756 | BMP6/SPINT2 ratio | GCST90313529 | 5.18e-03 |
| 7757 | Nonalcoholic fatty liver disease | GCST90054782 | 5.18e-03 |
| 7758 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T119 | ECGU000119 | 5.18e-03 |
| 7759 | MVK levels | GCST90469967 | 5.17e-03 |
| 7760 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T146 | ECGU000146 | 5.15e-03 |
| 7761 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T88 | ECGA000088 | 5.15e-03 |
| 7762 | TNFRSF13B/TNFRSF13C ratio | GCST90315931 | 5.14e-03 |
| 7763 | Gestational diabetes (for exclusion) | FING00000573 | 5.13e-03 |
| 7764 | CX3CL1/RGMB ratio | GCST90314327 | 5.11e-03 |
| 7765 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 62) | GCST90320625 | 5.11e-03 |
| 7766 | APP/EGF ratio | GCST90313322 | 5.10e-03 |
| 7767 | AGRN/HSPG2 ratio | GCST90313201 | 5.09e-03 |
| 7768 | Plasma 3-hydroxyhexanoate levels in chronic kidney disease | GCST90264498 | 5.09e-03 |
| 7769 | GZMA/GZMH ratio | GCST90315008 | 5.09e-03 |
| 7770 | CLIP2/DAB2 ratio | GCST90314124 | 5.08e-03 |
| 7771 | Psoriasis (vulgaris), strict definition | FING00001223 | 5.08e-03 |
| 7772 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 77) | GCST90320896 | 5.08e-03 |
| 7773 | Hyperplasia of prostate | FING00000635 | 5.08e-03 |
| 7774 | CD46/TNFRSF14 ratio | GCST90313838 | 5.07e-03 |
| 7775 | CD164/NUDT5 ratio | GCST90313742 | 5.06e-03 |
| 7776 | DSCAM levels | GCST90469041 | 5.06e-03 |
| 7777 | LGALS3 levels | GCST90179303 | 5.06e-03 |
| 7778 | ACY1 levels | GCST90468212 | 5.05e-03 |
| 7779 | Volume of right medial nucleus | GCST90474925 | 5.04e-03 |
| 7780 | Pulse pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000718 | 5.04e-03 |
| 7781 | Waist-hip ratio | GCST90278649 | 5.01e-03 |
| 7782 | Colorectal cancer, excluding all cancers (controls excluding all cancers) | FING00000317 | 5.01e-03 |
| 7783 | HMBS/UBAC1 ratio | GCST90315066 | 5.01e-03 |
| 7784 | T1 CAT volume R RightThalamus | GCST90384097 | 5.00e-03 |
| 7785 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T20 | ECGA000020 | 4.99e-03 |
| 7786 | aseg rh intensity Accumbens-area | GCST90003788 | 4.99e-03 |
| 7787 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T144 | ECGA000144 | 4.99e-03 |
| 7788 | Diastolic blood pressure | GCST90018732 | 4.98e-03 |
| 7789 | Squamous cell carcinoma (PheCode 172.22) | GCST90475583 | 4.98e-03 |
| 7790 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 3.04_132.06) | GCST90291582 | 4.98e-03 |
| 7791 | AK2 levels | GCST90468270 | 4.97e-03 |
| 7792 | PAPPA levels | GCST90470157 | 4.97e-03 |
| 7793 | DAB2/GRAP2 ratio | GCST90314364 | 4.96e-03 |
| 7794 | ACY1/GSTA1 ratio | GCST90313163 | 4.96e-03 |
| 7795 | Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers) | FING00000041 | 4.95e-03 |
| 7796 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T256 | ECGU000256 | 4.95e-03 |
| 7797 | FGL1 levels | GCST90469235 | 4.94e-03 |
| 7798 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T148 | ECGU000148 | 4.94e-03 |
| 7799 | DTI autoptx L2 unc r tract | GCST90385192 | 4.94e-03 |
| 7800 | Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers) | FING00000772 | 4.93e-03 |
| 7801 | LILRB4 levels | GCST90426708 | 4.92e-03 |
| 7802 | Osteoarthritis of the hip or knee | GCST007092 | 4.92e-03 |
| 7803 | Phospholipids in IDL | GCST90497626 | 4.92e-03 |
| 7804 | APEX1 levels | GCST90468329 | 4.91e-03 |
| 7805 | PRCP/SELE ratio | GCST90315726 | 4.90e-03 |
| 7806 | aparc-pial rh area fusiform | GCST90003180 | 4.89e-03 |
| 7807 | eosinophil (absolute count, minimum, inv-norm transformed) | GCST90475294 | 4.89e-03 |
| 7808 | Pollen allergy | FING00001176 | 4.86e-03 |
| 7809 | CES1 levels | GCST90468718 | 4.86e-03 |
| 7810 | COMT levels | GCST90468828 | 4.85e-03 |
| 7811 | Operative procedures - Unspecified diagnostic endoscopic examination of colon | Summary Operations | UKBB00000591 | 4.85e-03 |
| 7812 | FAM3B/FGF19 ratio | GCST90314776 | 4.84e-03 |
| 7813 | Benign neoplasm: Colon, unspecified | FING00000172 | 4.84e-03 |
| 7814 | ALCAM levels | GCST90468279 | 4.84e-03 |
| 7815 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502388 | 4.82e-03 |
| 7816 | Estimated glomerular filtration rate (creatinine) | GCST90428447 | 4.82e-03 |
| 7817 | HDL cholesterol levels (UKB data field 30760) | GCST90468075 | 4.81e-03 |
| 7818 | FGR/LBR ratio | GCST90314814 | 4.80e-03 |
| 7819 | Cleft hard palate NOS | FING00000306 | 4.79e-03 |
| 7820 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T38 | ECGA000038 | 4.79e-03 |
| 7821 | IDP dMRI TBSS L3 Cerebral peduncle R | GCST90004185 | 4.78e-03 |
| 7822 | TXNRD1 levels | GCST90470994 | 4.77e-03 |
| 7823 | Linoleic acid levels | GCST90502307 | 4.77e-03 |
| 7824 | Hypothyroidism | GCST90468138 | 4.77e-03 |
| 7825 | Mean corpuscular volume | GCST004602 | 4.76e-03 |
| 7826 | IDP dMRI ProbtrackX L3 cgc l | GCST90004304 | 4.76e-03 |
| 7827 | Psoriatic arthropathies | FING00001225 | 4.74e-03 |
| 7828 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T28 | ECGA000028 | 4.74e-03 |
| 7829 | Triglyceride levels (UKB data field 30870) | GCST90468106 | 4.73e-03 |
| 7830 | ARHGAP25 levels | GCST90468353 | 4.73e-03 |
| 7831 | PCBD1 levels | GCST90470166 | 4.72e-03 |
| 7832 | Total testosterone levels | GCST90239819 | 4.72e-03 |
| 7833 | Triglycerides | GCST90018755 | 4.71e-03 |
| 7834 | MGLL/MITD1 ratio | GCST90315436 | 4.71e-03 |
| 7835 | PEBP1 levels | GCST90470205 | 4.71e-03 |
| 7836 | CD5/CD6 ratio | GCST90313860 | 4.71e-03 |
| 7837 | SH2B3/TBL1X ratio | GCST90315841 | 4.70e-03 |
| 7838 | Genital prolapse | genitourinary | UKBB00000282 | 4.69e-03 |
| 7839 | Pregnanediol-3-glucuronide levels | GCST90199917 | 4.69e-03 |
| 7840 | GC levels | GCST90162564 | 4.67e-03 |
| 7841 | Polycystic ovarian syndrome | FING00001182 | 4.67e-03 |
| 7842 | MED18/ZBTB16 ratio | GCST90315416 | 4.66e-03 |
| 7843 | Seropositive rheumatoid arthritis, wide | FING00001298 | 4.65e-03 |
| 7844 | CIRBP levels | GCST90468756 | 4.65e-03 |
| 7845 | Triglycerides to Total Lipids in Large VLDL percentage | GCST90498287 | 4.65e-03 |
| 7846 | SUSD4 levels | GCST90470788 | 4.65e-03 |
| 7847 | CD5L levels | GCST90468640 | 4.64e-03 |
| 7848 | Mean corpuscular hemoglobin concentration | GCST90002328 | 4.64e-03 |
| 7849 | APRT/MIF ratio | GCST90313336 | 4.63e-03 |
| 7850 | CCN1 levels | GCST90468587 | 4.63e-03 |
| 7851 | Hematocrit | GCST90002383 | 4.62e-03 |
| 7852 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 2) | GCST90320821 | 4.61e-03 |
| 7853 | JCHAIN levels | GCST90469661 | 4.61e-03 |
| 7854 | BA-exvivo rh volume BA4p | GCST90002854 | 4.60e-03 |
| 7855 | GPHA2 levels | GCST90469389 | 4.60e-03 |
| 7856 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T257 | ECGA000257 | 4.60e-03 |
| 7857 | Nontoxic diffuse goitre | FING00000886 | 4.59e-03 |
| 7858 | LRRFIP1 levels | GCST90469805 | 4.59e-03 |
| 7859 | Basal cell carcinoma (PheCode 172.21) | GCST90475582 | 4.59e-03 |
| 7860 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T126 | ECGA000126 | 4.58e-03 |
| 7861 | Abnormal findings examination of lungs (PheCode 514) | GCST90476043 | 4.57e-03 |
| 7862 | MAP4K5 levels | GCST90469855 | 4.57e-03 |
| 7863 | ITGB1BP2/WASF1 ratio | GCST90315224 | 4.57e-03 |
| 7864 | REG1A levels | GCST90470447 | 4.57e-03 |
| 7865 | Glaucoma | Glaucoma | UKBB00000286 | 4.56e-03 |
| 7866 | DTI TBSS MD Posterior thalamic radiation R | GCST90384600 | 4.55e-03 |
| 7867 | Coronary artery disease (confirmatory factor analysis Factor 16) | GCST90309350 | 4.55e-03 |
| 7868 | BTN2A1/SPINT2 ratio | GCST90313550 | 4.54e-03 |
| 7869 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97) | GCST90320660 | 4.53e-03 |
| 7870 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T22 | ECGU000022 | 4.53e-03 |
| 7871 | Urate levels (UKB data field 30880) | GCST90468107 | 4.53e-03 |
| 7872 | FCN1 levels | GCST90469203 | 4.52e-03 |
| 7873 | 3,4-dihydroxybutyrate levels | GCST90199816 | 4.51e-03 |
| 7874 | Disorders of other endocrine glands | FING00000450 | 4.51e-03 |
| 7875 | PEAR1/TREML2 ratio | GCST90315645 | 4.50e-03 |
| 7876 | Fracture at wrist and hand level | FING00000551 | 4.50e-03 |
| 7877 | Medication use (immunosuppressants) | GCST90018771 | 4.48e-03 |
| 7878 | Autoimmune polyglandular failure | FING00000135 | 4.47e-03 |
| 7879 | aparc-Desikan rh area cuneus | GCST90003111 | 4.45e-03 |
| 7880 | Omega-6 fatty acid levels | GCST90502101 | 4.45e-03 |
| 7881 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 16) | GCST90320579 | 4.45e-03 |
| 7882 | FGF2 levels | GCST90469224 | 4.44e-03 |
| 7883 | CNTN5/ROBO2 ratio | GCST90314166 | 4.44e-03 |
| 7884 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T215 | ECGA000215 | 4.44e-03 |
| 7885 | Serum 25-Hydroxyvitamin D level variance | GCST90000621 | 4.43e-03 |
| 7886 | IDP dMRI ProbtrackX MD ar r | GCST90004220 | 4.43e-03 |
| 7887 | PRCP levels | GCST90470314 | 4.43e-03 |
| 7888 | Triglyceride levels in large HDL | GCST90092854 | 4.43e-03 |
| 7889 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T182 | ECGA000182 | 4.43e-03 |
| 7890 | Acquired deformities of fingers and toes | Other joint disorders | UKBB00000006 | 4.42e-03 |
| 7891 | Father's age at death | Family history | UKBB00000241 | 4.40e-03 |
| 7892 | IKBKG levels | GCST90469542 | 4.40e-03 |
| 7893 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T133 | ECGA000133 | 4.40e-03 |
| 7894 | RECK levels | GCST90470445 | 4.40e-03 |
| 7895 | Polyunsaturated fatty acid levels | GCST90502619 | 4.39e-03 |
| 7896 | Ischemic stroke | GCST006908 | 4.39e-03 |
| 7897 | Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000720 | 4.39e-03 |
| 7898 | Stroke (MTAG) | GCST90449063 | 4.39e-03 |
| 7899 | Alanine levels | GCST90497085 | 4.39e-03 |
| 7900 | Pulse pressure, automated reading | Cardiovascular measurement | UKBB00000714 | 4.39e-03 |
| 7901 | MANF/SNX9 ratio | GCST90315368 | 4.38e-03 |
| 7902 | Colon cancer | GCST90011811 | 4.38e-03 |
| 7903 | Operative procedures - Anastomosis of mammary artery to left anterior descending coronary artery | Summary Operations | UKBB00000571 | 4.38e-03 |
| 7904 | Omega-6 fatty acid levels | GCST90502515 | 4.36e-03 |
| 7905 | Varicose veins (PheCode 454) | GCST90476012 | 4.36e-03 |
| 7906 | Hemoglobin | GCST90002384 | 4.36e-03 |
| 7907 | LDLR/MEGF9 ratio | GCST90315310 | 4.33e-03 |
| 7908 | Total testosterone levels | GCST90239820 | 4.33e-03 |
| 7909 | Glaucoma | GCST90468129 | 4.33e-03 |
| 7910 | Triglycerides x low social support interaction (2df test) | GCST90570681 | 4.33e-03 |
| 7911 | ANXA4/CA13 ratio | GCST90313290 | 4.32e-03 |
| 7912 | STAT2 levels | GCST90470758 | 4.32e-03 |
| 7913 | GP6/SELP ratio | GCST90314970 | 4.31e-03 |
| 7914 | IGFBP4/OGN ratio | GCST90315134 | 4.31e-03 |
| 7915 | Retinal arteriolar tortuosity | GCST90270397 | 4.30e-03 |
| 7916 | IDP SWI T2star right thalamus | GCST90003864 | 4.29e-03 |
| 7917 | Other systemic involvement of connective tissue (FG) | FING00001116 | 4.29e-03 |
| 7918 | DTI TBSS L3 Posterior thalamic radiation L | GCST90384553 | 4.29e-03 |
| 7919 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T262 | ECGA000262 | 4.29e-03 |
| 7920 | PLAUR/PRSS8 ratio | GCST90315675 | 4.28e-03 |
| 7921 | CDH5/PCDH17 ratio | GCST90313958 | 4.28e-03 |
| 7922 | Optic disc area | GCST004076 | 4.28e-03 |
| 7923 | CRACR2A/DNMBP ratio | GCST90314226 | 4.28e-03 |
| 7924 | IDP dMRI TBSS ISOVF Fornix | GCST90004482 | 4.27e-03 |
| 7925 | AZU1/CEACAM8 ratio | GCST90313424 | 4.27e-03 |
| 7926 | TSC1 levels | GCST90470972 | 4.27e-03 |
| 7927 | Breast cancer | GCST004988 | 4.27e-03 |
| 7928 | Serum creatinine levels | GCST90018759 | 4.27e-03 |
| 7929 | Insulin fold change during an oral glucose tolerance test | GCST90267568 | 4.26e-03 |
| 7930 | IDP dMRI TBSS OD Posterior corona radiata L | GCST90004429 | 4.26e-03 |
| 7931 | NAGPA levels | GCST90242004 | 4.25e-03 |
| 7932 | Estimated glomerular filtration rate (creatinine) | GCST90103634 | 4.24e-03 |
| 7933 | CFC1 levels | GCST90468724 | 4.23e-03 |
| 7934 | Phospholipids to Total Lipids in Medium HDL percentage | GCST90498653 | 4.23e-03 |
| 7935 | SCARF1/TNFRSF14 ratio | GCST90315812 | 4.23e-03 |
| 7936 | Corneal resistance factor (left) | Intraocular pressure | UKBB00000150 | 4.23e-03 |
| 7937 | MPO levels | GCST90012031 | 4.22e-03 |
| 7938 | CXCL10 levels | GCST90274780 | 4.22e-03 |
| 7939 | IDS/SMPDL3A ratio | GCST90315126 | 4.22e-03 |
| 7940 | SESTD1 levels | GCST90470604 | 4.21e-03 |
| 7941 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121) | GCST90320940 | 4.21e-03 |
| 7942 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T108 | ECGA000108 | 4.20e-03 |
| 7943 | Total lipids in lipoprotein particles (UKB data field 23423) | GCST90269520 | 4.20e-03 |
| 7944 | SIGLEC5 levels | GCST90470633 | 4.19e-03 |
| 7945 | IDP dMRI TBSS L2 Corticospinal tract R | GCST90004129 | 4.19e-03 |
| 7946 | OLR1 levels | GCST90012020 | 4.19e-03 |
| 7947 | Left-hemisphere control network to hippocampus white-matter structural connectivity | GCST90302756 | 4.19e-03 |
| 7948 | MIF/PARK7 ratio | GCST90315447 | 4.18e-03 |
| 7949 | CCN2/VEGFC ratio | GCST90313719 | 4.17e-03 |
| 7950 | Triglycerides in small LDL | GCST90499722 | 4.16e-03 |
| 7951 | PPME1 levels | GCST90470298 | 4.14e-03 |
| 7952 | End-diastolic bi-ventricular shape (principal component 4) | GCST90448483 | 4.14e-03 |
| 7953 | PRTFDC1 levels | GCST90470346 | 4.14e-03 |
| 7954 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T120 | ECGA000120 | 4.14e-03 |
| 7955 | TJAP1 levels | GCST90470874 | 4.13e-03 |
| 7956 | Cholelithiasis | GCST90468118 | 4.13e-03 |
| 7957 | CPB1/REG1A ratio | GCST90314212 | 4.13e-03 |
| 7958 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T484 | ECGU000484 | 4.12e-03 |
| 7959 | Biliverdin levels in chronic kidney disease | GCST90257495 | 4.12e-03 |
| 7960 | Aspartate aminotransferase (AST, maximum, inv-norm transformed) | GCST90475118 | 4.12e-03 |
| 7961 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42) | GCST90320605 | 4.12e-03 |
| 7962 | aparc-Desikan lh area cuneus | GCST90003077 | 4.12e-03 |
| 7963 | COLEC12/OGN ratio | GCST90314184 | 4.12e-03 |
| 7964 | Gout (PheCode 274.1) | GCST90476379 | 4.12e-03 |
| 7965 | F2R/SPINT2 ratio | GCST90314737 | 4.11e-03 |
| 7966 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T171 | ECGA000171 | 4.10e-03 |
| 7967 | SSH3 levels | GCST90470749 | 4.10e-03 |
| 7968 | Disorders of plasma-protein metabolism, not elsewhere classified | FING00000455 | 4.10e-03 |
| 7969 | MAVS/MZT1 ratio | GCST90315391 | 4.09e-03 |
| 7970 | BECN1 levels | GCST90468438 | 4.09e-03 |
| 7971 | EDAR/F2R ratio | GCST90314577 | 4.09e-03 |
| 7972 | STX6 levels | GCST90470774 | 4.08e-03 |
| 7973 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T153 | ECGU000153 | 4.08e-03 |
| 7974 | NSFL1C levels | GCST90470089 | 4.06e-03 |
| 7975 | ITGB1BP2/MED18 ratio | GCST90315213 | 4.06e-03 |
| 7976 | Carpal tunnel syndrome | FING00000257 | 4.06e-03 |
| 7977 | Frailty (Factor 4 - Metabolic Problems) | GCST90624050 | 4.06e-03 |
| 7978 | Ulcerative colitis (PheCode 555.2) | GCST90044155 | 4.06e-03 |
| 7979 | Phospholipids in VLDL | GCST90500268 | 4.04e-03 |
| 7980 | Linoleic acid levels (UKB data field 23449) | GCST90269546 | 4.04e-03 |
| 7981 | Free Cholesterol in HDL | GCST90497379 | 4.04e-03 |
| 7982 | Concentration of medium HDL particles | GCST90498617 | 4.04e-03 |
| 7983 | CDSN/LY6D ratio | GCST90313997 | 4.03e-03 |
| 7984 | CPA1/CTRB1 ratio | GCST90314203 | 4.03e-03 |
| 7985 | ALDH1A1/CA3 ratio | GCST90313244 | 4.03e-03 |
| 7986 | Chronic lymphocytic leukemia | GCST90624738 | 4.03e-03 |
| 7987 | Hepatic cancer | GCST90018638 | 4.02e-03 |
| 7988 | YBX1 levels | GCST90090799 | 4.01e-03 |
| 7989 | aseg rh intensity Pallidum | GCST90003785 | 4.00e-03 |
| 7990 | GALNT7 levels | GCST90469299 | 4.00e-03 |
| 7991 | TNFRSF13B/TNFRSF9 ratio | GCST90315932 | 4.00e-03 |
| 7992 | TFF1/TFF2 ratio | GCST90315914 | 4.00e-03 |
| 7993 | Hypo-osmolality and hyponatraemia | FING00000648 | 4.00e-03 |
| 7994 | PCDH17/SEMA7A ratio | GCST90315605 | 3.99e-03 |
| 7995 | LAP3 levels | GCST90469737 | 3.99e-03 |
| 7996 | Reimbursement for rheumatic diseases | FING00001247 | 3.99e-03 |
| 7997 | FCER2/TCL1A ratio | GCST90314790 | 3.99e-03 |
| 7998 | Right-hemisphere default mode network to amygdala white-matter structural connectivity | GCST90302849 | 3.98e-03 |
| 7999 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T187 | ECGA000187 | 3.98e-03 |
| 8000 | IDP dMRI TBSS MO Middle cerebellar peduncle | GCST90003952 | 3.98e-03 |